Why India Bears 90% of the Global Chewing Tobacco Burden
The global chewing tobacco health burden remains heavily concentrated in a small group of nations, with South Asia at its core. Published in The Lancet Global Health, the Global Burden of Disease Study 2023 estimates that chewing tobacco caused 251,000 deaths worldwide in 2023. Furthermore, South Asia accounted for 210,000 of these fatalities, representing roughly 84% of total global mortality. India bears an enormous share of this preventable morbidity and premature death. Consequently, Indian healthcare practitioners must recognize this unique epidemiological pattern to intervene effectively during routine clinical consultations.
The Alarming Chewing Tobacco Health Burden in India
Notably, the study assessed exposure across 204 countries and territories from 1990 to 2023. Over this 33-year period, the global prevalence of chewing tobacco remained virtually unchanged. Approximately 241 million adults globally chewed tobacco in 2023. In addition, South Asia demonstrated an adult prevalence rate of 14.6%, far exceeding international averages.
More than 90% of male deaths and disability occur in only ten nations, with India and Bangladesh leading this cohort. Similarly, female morbidity concentrates heavily in India, Pakistan, and Bangladesh. In India, widespread cultural acceptance of products like khaini, gutkha, and zarda accelerates this epidemic. As a result, older adults bear the heaviest brunt, with usage rates peaking among individuals aged 60 to 64 years.
Primary Clinical Manifestations: Oral Malignancies and Stroke
Chewing tobacco presents distinct pathophysiological risks compared to smoked tobacco. For instance, oral mucosal absorption of tobacco-specific nitrosamines directly initiates cellular mutations. Therefore, lip and oral cavity cancers constitute a substantial fraction of tobacco-related disability. In fact, chewing tobacco accounts for 17.3% of global lip and oral cancer disability-adjusted life years (DALYs). In South Asia, however, that figure surges to an astounding 30.5%.
Beyond oncological diseases, the study highlights stroke as another leading driver of chewing tobacco-attributable health loss. Chronic systemic absorption of high nicotine doses triggers endothelial dysfunction and arterial stiffness. Consequently, users face heightened risks of severe cerebrovascular ischemic events. Most clinical losses stem from premature death, emphasizing that clinicians must catch vascular and malignant signs early.
Actionable Strategies for Healthcare Practitioners
Because chewing tobacco habits vary widely by demographic, a uniform intervention strategy will fail. Thus, primary care physicians must adopt targeted cessation protocols.
First, clinicians should screen all adult patients for smokeless tobacco use, regardless of smoking history. Specifically, doctors must examine the oral cavity thoroughly for leukoplakia, erythroplakia, and mucosal changes during every routine visit. Second, physicians should explain cardiovascular and stroke risks clearly to habitual users. Nicotine replacement therapy and behavioral counseling offer viable pathways to cessation. Finally, public health programs must address gender-specific cultural nuances, particularly among rural women and elderly demographics.
Frequently Asked Questions
Q1: Why is South Asia disproportionately affected by chewing tobacco?
South Asia accounts for roughly 84% of global chewing tobacco deaths due to deeply rooted sociocultural traditions, high accessibility, and widespread use of products like gutkha, khaini, and zarda.
Q2: What are the primary health complications linked to chewing tobacco?
According to the Global Burden of Disease Study 2023, oral cavity and lip cancers, alongside stroke, constitute the majority of death and disability attributable to chewing tobacco.
Q3: How can Indian doctors assist patients with smokeless tobacco cessation?
Clinicians can implement proactive oral screenings, provide behavioral counseling, and recommend pharmacotherapies like nicotine replacement therapy tailored to individual patient risk profiles.
References
- World's 90% health burden of chewing tobacco concentrated in 10 countries,including India: Study - ETHealthworld
- GBD 2023 Chewing Tobacco Collaborators. Global, regional, and national burden of exposure to chewing tobacco, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023. The Lancet Global Health. 2026.
- World Health Organization. Tobacco Control in India: Prevalence, Mortality, and Policy Challenges. WHO Regional Office for South-East Asia. 2026.
